跳至主要内容
临床试验/EUCTR2012-004071-39-IT
EUCTR2012-004071-39-IT进行中(未招募)不适用

Study on the effectiveness and safety of the treatment of mild-moderate symptomatic hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone (SIADH) with Tolvaptan vs fluid restriction in patients who underwent transsphenoidal surgery for hypothalamic-pituitary disorders.

FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO0 个研究点开始时间: 2012年10月31日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - age >18
  • - admission to Neurosurgery Unit for pituitary surgery
  • - Serum sodium levels lower than 135 mEq/l and higher than 120 mEq/l
  • - One or more symptoms of hyponatremia
  • - Euvolemic patient
  • - Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • - Impaired renal function(grade IV KDOQI)
  • - Liver failure
  • - Hypovolemia
  • - Hyponatremic hypovolemia
  • - Lack of sense to thirst
  • - Cotreatment with inhibitors/inductors of CYP3A4
  • - Pregnancy
  • - Brestfeeding

研究者

发起方
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO

相似试验